Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | MAP3K8 | P41279 | 2/20 | 0.33 |
| ▸ | PTGIR | P43119 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
| ▸ | F9 | P00740 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | ACLY | P53396 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16475619 | 0.85 | PTGIR (0.31) | PTGIR | |
| SCHEMBL17945768 | 0.84 | MEN1 (0.34) | PDK2F9MEN1POLBMAPT | |
| SCHEMBL17550923 | 0.84 | PTGIR (0.38) | PDK2MAP3K8PTGIRHDAC1IDO1 | |
| SCHEMBL23372693 | 0.83 | MAP3K8 (0.34) | PDK2MAP3K8F9MEN1MAPT | |
| SCHEMBL17690164 | 0.83 | PDK2 (0.38) | PDK2PTGIRIDO1F9 | |
| SCHEMBL25003257 | 0.83 | PDK2 (0.34) | PDK2 | |
| SCHEMBL23372691 | 0.83 | F9 (0.34) | PDK2F9 | |
| SCHEMBL21863063 | 0.82 | ALK (0.33) | F9MEN1POLBMAPTDUSP3 | |
| SCHEMBL24406557 | 0.81 | ALK (0.33) | F9MEN1POLBMAPTDUSP3 | |
| SCHEMBL23372692 | 0.81 | MAP3K8 (0.33) | MAP3K8IDO1ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9246107-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the organic light emitting diode | CHEIL INDUSTRIES, INC. (KR) | 2016-01-26 | — | — | US | disclosed |
| US-9246107-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the organic light emitting diode | CHEIL INDUSTRIES, INC. (KR) | 2016-01-26 | — | — | US | disclosed |
| US-20120112174-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-05-10 | — | — | US | disclosed |
| US-20120112174-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120112174-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | AOX1, OCIAD1, OCIAD2 | PDK2 1621/4885MAP3K8 1824/4885PTGIR 3321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.